According to Sorrento Therapeutics 's latest financial reports the company's current revenue (TTM ) is C$88.46 Million. In 2022 the company made a revenue of C$85.27 Million an increase over the revenue in the year 2021 that were of C$67.42 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.